Renal cell carcinoma echocardiography or ultrasound: Difference between revisions
Farima Kahe (talk | contribs) |
Farima Kahe (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}} | {{CMG}} {{AE}} {{F.K}} | ||
{{Renal cell carcinoma}} | {{Renal cell carcinoma}} | ||
==Overview== | ==Overview== | ||
Ultrasound (US) may be helpful when CT scan results are equivocal. | Ultrasound may be helpful in the diagnosis of renal cell carcinoma. Ultrasound (US) may be helpful when CT scan results are equivocal. | ||
==Ultrasound== | ==Ultrasound== | ||
Revision as of 14:56, 27 July 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]
|
Renal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Renal cell carcinoma echocardiography or ultrasound On the Web |
|
American Roentgen Ray Society Images of Renal cell carcinoma echocardiography or ultrasound |
|
Renal cell carcinoma echocardiography or ultrasound in the news |
|
Blogs on Renal cell carcinoma echocardiography or ultrasound |
|
Risk calculators and risk factors for Renal cell carcinoma echocardiography or ultrasound |
Overview
Ultrasound may be helpful in the diagnosis of renal cell carcinoma. Ultrasound (US) may be helpful when CT scan results are equivocal.
Ultrasound
Ultrasound may be helpful in the diagnosis of renal cell carcinoma. Ultrasound (US) may be helpful when CT scan results are equivocal.
| Patient Profile | Use of US | Evidence Strength |
| Low Risk Patient (pT1, N0, Nx) | US (or CT or MRI) may be performed in patients following radical nephrectomy if initial post-op baseline image is negative | C |
| Moderate to High Risk Patients (pT2-4N0 Nx or any stage N+) | Imaging, including US, may be used every 6 months (after a baseline chest and abdominal CT or MRI within 3-6 months following surgery) for at least 3 years and annually thereafter to 5 years. Site specific imaging is warranted by clinical symptoms suggestive of recurrence or metastatic spread. Imaging (US, CXR, CT, or MRI) beyond 5 years may be performed at the discretion of the clinician | C |
References
- ↑ Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH; et al. (2013). "Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline". J Urol. 190 (2): 407–16. doi:10.1016/j.juro.2013.04.121. PMID 23665399.